1. Home
  2. EARN vs GNFT Comparison

EARN vs GNFT Comparison

Compare EARN & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • GNFT
  • Stock Information
  • Founded
  • EARN 2012
  • GNFT 1999
  • Country
  • EARN United States
  • GNFT France
  • Employees
  • EARN N/A
  • GNFT N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EARN Real Estate
  • GNFT Health Care
  • Exchange
  • EARN Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • EARN 187.6M
  • GNFT 172.2M
  • IPO Year
  • EARN 2013
  • GNFT 2019
  • Fundamental
  • Price
  • EARN $6.61
  • GNFT $3.60
  • Analyst Decision
  • EARN Hold
  • GNFT Strong Buy
  • Analyst Count
  • EARN 1
  • GNFT 1
  • Target Price
  • EARN N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • EARN 516.1K
  • GNFT 3.9K
  • Earning Date
  • EARN 03-05-2025
  • GNFT 09-19-2024
  • Dividend Yield
  • EARN 14.52%
  • GNFT N/A
  • EPS Growth
  • EARN 277.67
  • GNFT N/A
  • EPS
  • EARN 1.02
  • GNFT 0.47
  • Revenue
  • EARN N/A
  • GNFT $86,225,222.00
  • Revenue This Year
  • EARN N/A
  • GNFT $145.20
  • Revenue Next Year
  • EARN $89.08
  • GNFT N/A
  • P/E Ratio
  • EARN $6.46
  • GNFT $7.58
  • Revenue Growth
  • EARN N/A
  • GNFT 175.45
  • 52 Week Low
  • EARN $5.54
  • GNFT $3.35
  • 52 Week High
  • EARN $7.26
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • EARN 49.91
  • GNFT 42.09
  • Support Level
  • EARN $6.30
  • GNFT $3.35
  • Resistance Level
  • EARN $6.79
  • GNFT $3.66
  • Average True Range (ATR)
  • EARN 0.14
  • GNFT 0.10
  • MACD
  • EARN 0.01
  • GNFT 0.03
  • Stochastic Oscillator
  • EARN 55.36
  • GNFT 45.45

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: